Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview

International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature

Philip M. Murphy
Pharmacological Reviews June 2002, 54 (2) 227-229; DOI: https://doi.org/10.1124/pr.54.2.227
Philip M. Murphy
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

An update of the International Union of Pharmacology nomenclature for chemokines is outlined, defining one new receptor type, CXCR6, and disqualifying the putative receptor, CCR11.

I. Introduction

In the year 2000, the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR2) approved a nomenclature system for chemokine receptors, the major seven transmembrane (7TM) receptors of the immune system, as recommended by the NC-IUPHAR Chemokine Receptor Subcommittee (Murphy et al., 2000). At that time, the chemokine receptor family consisted of 18 7TM proteins in humans, which were divided into four subfamilies based on chemokine subclass specificity. Two additional molecules, named Duffy and D6, which both have 7TM structure and bind chemokines but lack a known signaling function, were excluded from the nomenclature system, as were a group of functional 7TM chemokine receptors encoded by herpesviruses (Rosenkilde et al., 2001). The nomenclature system is logical, noncontroversial, and universally accepted and used (Table1). Moreover, it has served as a template for the creation of a chemokine ligand nomenclature system (Zlotnik and Yoshie, 2000). Both systems have facilitated communication among immunologists and pharmacologists as these molecules have become important drug targets in immunologically mediated disease and HIV/acquired immunodeficiency syndrome. Since publication of the NC-IUPHAR document reporting the nomenclature system in the year 2000, one new receptor subtype, CXCR6, has been identified (Matloubian et al., 2000; Wilbanks et al., 2001), and one other subtype, CCR11, has been disqualified (Schweickart et al., 2000, 2001). Duffy and D6 remain as binding sites. The aim of the present article is to provide a brief update on these receptors.

View this table:
  • View inline
  • View popup
Table 1

The chemokine receptor family

A. CXCR6

CXCR6 was originally cloned as an orphan receptor in 1997 by three independent groups who assigned three different names to it: STRL33 (seven transmembrane receptor-like from clone 33), BONZO, and TYMSTR (T lymphocyte-expressed seven-transmembrane domain receptor) (Alkhatib et al., 1997; Deng et al., 1997; Liao et al., 1997; Loetscher et al., 1997). It was considered most likely to be a chemokine receptor because 1) the gene was located on human chromosome 3p21 within the major chemokine receptor cluster, 2) the sequence was most highly related to chemokine receptors, 3) the RNA was expressed in activated T lymphocytes, and 4) like many other chemokine receptors, it could function as a cell entry factor for HIV. A particularly interesting feature is its ability to support cell entry by simian immunodeficiency virus and both X4 and R5 strains of HIV.

Although many chemokine receptors have multiple shared ligands, CXCR6 binds a distinct ligand, designated CXCL16 (Matloubian et al., 2000;Wilbanks et al., 2001). CXCL16 has a unique hybrid structure, with features heretofore found separately in two other chemokine subclasses. In particular, it has the CXC motif, which defines members of the CXC subclass of chemokines, and a multimodular structure consisting of a transmembrane region and a chemokine domain suspended by a mucin-like stalk previously found only for the CX3C chemokine CX3CL1. The CXCL16 chemokine domain also has characteristics of the CC chemokine subclass. CXCL16 is expressed on the surface of antigen-presenting cells (B cells, macrophages, dendritic cells in lymphoid organ T cell zones) and by cells in the splenic red pulp (Matloubian et al., 2000). Functional CXCL16 is also shed from macrophages (Wilbanks et al., 2001). CXCR6 is expressed preferentially on memory T cells and on activated Th1 and Tc1 effector T cell subsets (Unutmaz et al., 2000; Kim et al., 2001). The exact biological role of CXCL16/CXCR6 is unknown, but reasonable hypotheses for this role include attraction of activated T lymphocyte subsets during inflammation, facilitation of immune responses via cell-cell contact, and guidance of T cell trafficking in the splenic red pulp. CXCL16 is also expressed in the thymic medulla and in some nonlymphoid tissues, suggesting roles in thymocyte development.

B. CCR11

The human homolog of the bovine orphan gustatory receptor PPR1 was originally designated CCR11 based on a report by Schweickart et al. (2000) indicating that, when expressed in a transformed mouse B cell line, it functioned as a chemotactic receptor for the monocyte chemoattractant protein family of chemokines (CCL2, CCL8 and CCL13). However, an independent report, published in the same month, found that this same molecule (which was designated by a different name, CCR10) did not bind these chemokines, but instead bound CCL19, CCL21 and CCL25 with high affinity (Gosling et al., 2000). Nevertheless, no signaling function could be identified. On review, the first group confirmed that CCR11 bound CCL19, CCL21 and CCL25 in two independent cell lines and found that the original transfected cell line used in their study expressed RNA for endogenous mouse CCR2, a known receptor for CCL2, CCL8, and CCL13, but lacked detectable RNA for exogenous CCR11 (Schweickart et al., 2001). They concluded that the original data were not due to CCR11 but instead may be attributable to up-regulation of endogenous murine CCR2 gene. Since there is now no signaling response ascribed to the receptor, this molecule does not qualify for a CCR# designation and the terms CCR10 or CCR11 should no longer be used to describe it. Moreover, at approximately the same time in 2000, two groups independently identified the receptor for CCL27, which they named CCR10 (Homey et al., 2000; Jarmin et al., 2000). Since this molecule mediates chemotactic signaling, it is a bona fide chemokine receptor and qualifies for this designation.

Footnotes

  • ↵1 Chairman of the Subcommittee on Chemokine Receptors, International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.

  • Address correspondence to: Dr. Philip M. Murphy, Laboratory of Host Defenses, Bldg. 10, Room 11N113, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892. E-mail: pmm{at}nih.gov

Abbreviations

NC-IUPHAR
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification
7TM
seven transmembrane
HIV
human immunodeficiency virus
  • U.S. Government

References

  1. ↵
    1. Alkhatib G,
    2. Liao F,
    3. Berger EA,
    4. Farber JM, and
    5. Peden KW
    (1997) A new SIV co-receptor, STRL33. Nature (Lond) 388:238.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Deng HK,
    2. Unutmaz D,
    3. KewalRamani VN, and
    4. Littman DR
    (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (Lond) 388:296–300.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Gosling J,
    2. Dairaghi DJ,
    3. Wang Y,
    4. Hanley M,
    5. Talbot D,
    6. Miao Z, and
    7. Schall TJ
    (2000) Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC and TECK. J Immunol 164:2851–2856.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Homey B,
    2. Wang W,
    3. Soto H,
    4. Buchanan ME,
    5. Wiesenborn A,
    6. Catron D,
    7. Muller A,
    8. McClanahan TK,
    9. Dieu-Nosjean MC,
    10. Orozco R,
    11. et al.
    (2000) Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164:3465–3470.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Jarmin DI,
    2. Rits M,
    3. Bota D,
    4. Gerard NP,
    5. Graham GJ,
    6. Clark-Lewis I, and
    7. Gerard C
    (2000) Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. J Immunol 164:3460–3464.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Kim CH,
    2. Kunkel EJ,
    3. Boisvert J,
    4. Johnston B,
    5. Campbell JJ,
    6. Genovese MC,
    7. Greenberg HB, and
    8. Butcher EC
    (2001) Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Investig 107:595–601.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Liao F,
    2. Alkhatib G,
    3. Peden KW,
    4. Sharma G,
    5. Berger EA, and
    6. Farber JM
    (1997) STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185:2015–2023.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Loetscher M,
    2. Amara A,
    3. Oberlin E,
    4. Brass N,
    5. Legler D,
    6. Loetscher P,
    7. D'Apuzzo M,
    8. Meese E,
    9. Rousset D,
    10. Virelizier JL,
    11. et al.
    (1997) TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol 7:652–660.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Matloubian M,
    2. David A,
    3. Engel S,
    4. Ryan JE, and
    5. Cyster JG
    (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298–304.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Murphy PM,
    2. Baggiolini M,
    3. Charo IF,
    4. Hebert CA,
    5. Horuk R,
    6. Matsushima K,
    7. Miller LH,
    8. Oppenheim JJ, and
    9. Power CA
    (2000) International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145–176.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Rosenkilde MM,
    2. Waldhoer M,
    3. Luttichau HR, and
    4. Schwartz TW
    (2001) Virally encoded 7TM receptors. Oncogene 20:1582–1593.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Schweickart VL,
    2. Epp A,
    3. Raport CJ, and
    4. Gray PW
    (2000) CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines. J Biol Chem 275:9550–9556.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Schweickart VL,
    2. Epp A,
    3. Raport CJ, and
    4. Gray PW
    (2001) CCR11 is a functional receptor for the monocyte chemoaattractant protein family of chemokines. J Biol Chem 276:856.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Unutmaz D,
    2. Xiang W,
    3. Sunshine MJ,
    4. Campbell J,
    5. Butcher E, and
    6. Littman DR
    (2000) The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 165:3284–3292.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Wilbanks A,
    2. Zondlo SC,
    3. Murphy K,
    4. Mak S,
    5. Soler D,
    6. Langdon P,
    7. Andrew DP,
    8. Wu L, and
    9. Briskin M
    (2001) Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC and CX3C chemokines. J Immunol 166:5145–5154.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Zlotnik A and
    2. Yoshie O
    (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Pharmacological Reviews: 54 (2)
Pharmacological Reviews
Vol. 54, Issue 2
1 Jun 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview

International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature

Philip M. Murphy
Pharmacological Reviews June 1, 2002, 54 (2) 227-229; DOI: https://doi.org/10.1124/pr.54.2.227

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Review ArticleReview

International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature

Philip M. Murphy
Pharmacological Reviews June 1, 2002, 54 (2) 227-229; DOI: https://doi.org/10.1124/pr.54.2.227
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels
  • International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology
  • G Protein Modulation of Voltage-Gated Calcium Channels
Show more REVIEW

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics